StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research report report published on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE:BTX opened at $3.42 on Friday. The business’s 50-day moving average price is $3.93 and its 200 day moving average price is […]